Exploring New Approaches in AML Treatment
June 22, 2021
Topics Covered
We invite you to learn more about:
- Emerging therapies for acute myeloid leukemia (AML)
- Precision medicine for AML
- Managing side-effects
- The importance of open communication with your treatment team
Program Materials
Speaker
Joseph G. Jurcic, MD
Professor of Medicine
Columbia University Irving Medical Center
Director, Hematologic Malignancies
Attending Physician, New York-Presbyterian Hospital
Member, Herbert Irving Comprehensive Cancer Center
New York, NY
Program Support
Support for this program is provided by Agios; Bristol Myers Squibb; Genentech, Inc. & Biogen, and Jazz Pharmaceuticals.